Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion

Author:

Nasamu Armiyaw S.12ORCID,Glushakova Svetlana3ORCID,Russo Ilaria4ORCID,Vaupel Barbara12,Oksman Anna12,Kim Arthur S.15ORCID,Fremont Daved H.5,Tolia Niraj2,Beck Josh R.12,Meyers Marvin J.6ORCID,Niles Jacquin C.7ORCID,Zimmerberg Joshua3ORCID,Goldberg Daniel E.12ORCID

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.

2. Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO 63110, USA.

3. Section on Integrative Biophysics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

4. Faculty of Biology, Medicine and Health, Division of Infection Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, UK.

5. Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.

6. Center for World Health and Medicine, Saint Louis University School of Medicine, Saint Louis, MO 63104, USA.

7. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Abstract

Plasmodium parasite entrance and exit Sweats and fever are the hallmarks of malaria. Red blood cells are the replication factories for malaria parasites. Fever occurs when the parasites' merozoite stages burst en masse from red blood cells into the circulation. Nasamu et al. and Pino et al. discovered that two parasite proteases, plasmepsin IX and X, are essential for mass cell exit (see the Perspective by Boddey). Plasmepsin X is also used by the merozoites to enter a fresh red blood cell to continue the replicative cycle. These two plasmepsins act by regulating the maturation of enzymes required to disrupt host cell membranes. Because these functions are essential for the parasite, the authors used protease inhibitors to show that plasmepsins provide potential drug targets. Science , this issue p. 518 , p. 522 ; see also p. 445

Funder

NIH Office of the Director

National Institute of Allergy and Infectious Diseases

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3